4.8 Article

CD27 sustains survival of CTLs in virus-infected nonlymphoid tissue in mice by inducing autocrine IL-2 production

期刊

JOURNAL OF CLINICAL INVESTIGATION
卷 120, 期 1, 页码 168-178

出版社

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI40178

关键词

-

资金

  1. The Netherlands Organization for Scientific Research (NWO) [912-04-032]
  2. Dutch Cancer Society [NKI-2003-2859]

向作者/读者索取更多资源

Immunity to infections relies on clonal expansion of CD8(+) T cells, their maintenance as effector CTLs, and their selection into a memory population. These processes rely on delivery of survival signals to activated CD8(+) T cells. We here reveal the mechanism by which costimulatory CD27-CD70 interactions sustain survival of CD8(+) effector T cells in infected tissue. By unbiased genome-wide gene expression analysis, we identified the Il2 gene as the most prominent CD27 target gene in murine CD8(+) T cells. In vitro, CD27 directed IL-2 expression and promoted clonal expansion of primed CD8+ T cells exclusively by IL-2-dependent survival signaling. In mice intranasally infected with influenza virus, Cd27(-/-) CD8(+) effector T cells displayed reduced IL-2 production, accompanied by impaired accumulation in lymphoid organs and in the lungs, which constitute the tissue effector site. Reconstitution of Cd27(-/-) CD8(+) T cells with the IL2 gene restored their accumulation to wild-type levels in the lungs, but it did not rescue their accumulation in lymphoid organs. Competition experiments showed that the IL-2 produced under the control of CD27 supported effector CD8(+) T cell survival in the lungs in an autocrine manner. We conclude that CD27 signaling directs the IL-2 production that is reportedly essential to sustain survival of virus-specific CTLs in nonlymphoid tissue.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Hematology

Bone marrow-derived myeloid progenitors as driver mutation carriers in high- and low-risk Langerhans cell histiocytosis

Yanling Xiao, Astrid G. S. van Halteren, Xin Lei, Jelske Borst, Eline Steenwijk, Tom de Wit, Joanna Grabowska, Rhianne Voogd, Paul Kemps, Jennifer Picarsic, Cor van den Bos, Jannie Borst

Article Multidisciplinary Sciences

The histone methyltransferase DOT1L prevents antigen-independent differentiation and safeguards epigenetic identity of CD8+ T cells

Eliza Mari Kwesi-Maliepaard, Muhammad Assad Aslam, Mir Farshid Alemdehy, Teun van den Brand, Chelsea McLean, Hanneke Vlaming, Tibor van Welsem, Tessy Korthout, Cesare Lancini, Sjoerd Hendriks, Tomasz Ahrends, Dieke van Dinther, Joke M. M. den Haan, Jannie Borst, Elzo de Wit, Fred van Leeuwen, Heinz Jacobs

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Oncology

Clinically applicable CD34+-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responses

Jesper van Eck van der Sluijs, Diede van Ens, Soley Thordardottir, Denise Vodegel, Inge Hermens, Anniek B. van der Waart, J. H. Frederik Falkenburg, Michel G. D. Kester, Iris de Rink, Mirjam H. M. Heemskerk, Jannie Borst, Nicolaas P. M. Schaap, Joop H. Jansen, Yanling Xiao, Harry Dolstra, Willemijn Hobo

Summary: Allogeneic stem cell transplantation followed by DC vaccination shows potential for hemato-oncology patients, but obtaining sufficient numbers of natural DCs, particularly cDC1s, remains a challenge. A culture protocol using donor-derived HPCs has been developed to address this issue.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)

Article Immunology

Flagellin/TLR5 Stimulate Myeloid Progenitors to Enter Lung Tissue and to Locally Differentiate Into Macrophages

Xin Lei, Jara Palomero, Iris de Rink, Tom de Wit, Martijn van Baalen, Yanling Xiao, Jannie Borst

Summary: This study reveals that Flagellin can recruit circulating M phi/OC progenitors into infected tissues through the TLR5 axis, which then stimulates these progenitors to differentiate locally into M phi s. This novel finding suggests that this pathway may enhance host protection against bacterial infection at mucosal sites, in addition to monocyte recruitment.

FRONTIERS IN IMMUNOLOGY (2021)

Review Immunology

Mechanism of action of PD-1 receptor/ligand targeted cancer immunotherapy

Jannie Borst, Julia Busselaar, Douwe M. T. Bosma, Ferry Ossendorp

Summary: The article explains the importance of the PD-1 checkpoint in cancer treatment by outlining how it regulates the CD8(+) T cell response. It also discusses the role of PD-1 during T cell priming and emphasizes the importance of CD4(+) T cell help in optimizing CTL efficacy.

EUROPEAN JOURNAL OF IMMUNOLOGY (2021)

Article Cell Biology

Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8+ T cells

Elisa Matas-Rico, Elselien Frijlink, Irene van der Haar Avila, Apostolos Menegakis, Maaike van Zon, Andrew J. Morris, Jan Koster, Fernando Salgado-Polo, Sander de Kivit, Telma Lanc, Antonio Mazzocca, Zoe Johnson, John Haanen, Ton N. Schumacher, Anastassis Perrakis, Inge Verbrugge, Joost H. van den Berg, Jannie Borst, Wouter H. Moolenaar

Summary: The study reveals that ATX secreted by melanoma cells repels tumor-infiltrating lymphocytes and circulating CD8(+) T cells, acting as a chaperone for LPA. Mechanistically, T cell repulsion is mainly involved G alpha(12/13)-coupled LPAR6, suppressing CD8(+) T cell infiltration and affecting tumor regression.

CELL REPORTS (2021)

Article Immunology

TNFR2 Costimulation Differentially Impacts Regulatory and Conventional CD4+ T-Cell Metabolism

Mark Mensink, Thi Ngoc Minh Tran, Esther A. Zaal, Ellen Schrama, Celia R. Berkers, Jannie Borst, Sander de Kivit

Summary: CD4(+) T cells play a role in immune responses depending on the environment and stage, with nutrient availability also impacting their functionality. TNFR2 has been identified as key in regulating T cells, particularly Tregs. This study provides new evidence for the role of TNFR2 in metabolic regulation.

FRONTIERS IN IMMUNOLOGY (2022)

Review Oncology

Trial watch: Dendritic cell (DC)-based immunotherapy for cancer

Raquel S. Laureano, Jenny Sprooten, Isaure Vanmeerbeerk, Daniel M. Borras, Jannes Govaerts, Stefan Naulaerts, Zwi N. Berneman, Benoit Beuselinck, Kalijn F. Bol, Jannie Borst, An Coosemans, Angeliki Datsi, Jitka Faucikova, Lisa Kinget, Bart Neyns, Gerty Schreibelt, Evelien Smits, Rudiger Sorg, Radek Spisek, Kris Thielemans, Sandra Tuyaerts, Steven De Vleeschouwer, I. Jolanda M. de Vries, Yanling Xiao, Abhishek D. Garg

Summary: DC-based vaccination for cancer treatment has advanced significantly over recent decades, but still shows suboptimal anti-tumor efficacy in the clinic. Current efforts are focused on improving the immunogenicity and efficacy of DC vaccines in oncology.

ONCOIMMUNOLOGY (2022)

Article Oncology

Preclinical characterization and clinical translation of pharmacodynamic markers for MK-5890: a human CD27 activating antibody for cancer immunotherapy

Lars Guelen, Thierry O. Fischmann, Jerelyn Wong, Smita Mauze, Marco Guadagnoli, Nikolina Babala, Jozef Wagenaars, Veronica Juan, David Rosen, Winnie Prosise, Maurice Habraken, Imke Lodewijks, Danling Gu, Judith Stammen-Vogelzangs, Ying Yu, Jeanne Baker, David Lutje Hulsik, Lilian Driessen-Engels, Dan Malashock, Joost Kreijtz, Astrid Bertens, Evert de Vries, Astrid Bovens, Arne Bramer, Yiwei Zhang, Richard Wnek, Sean Troth, Elliot Chartash, Konstantin Dobrenkov, Svetlana Sadekova, Andrea van Elsas, Jason K. Cheung, Laurence Fayadat-Dilman, Jannie Borst, Amy M. Beebe, Hans Van Eenennaam

Summary: MK-5890, a novel CD27 agonistic antibody, has the potential to complement PD-1 checkpoint inhibition in cancer immunotherapy and is currently undergoing clinical evaluation.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Article Multidisciplinary Sciences

CD4+ helper T cells endow cDC1 with cancer-impeding functions in the human tumor micro-environment

Xin Lei, Indu Khatri, Tom de Wit, Iris de Rink, Marja Nieuwland, Ron Kerkhoven, Hans van Eenennaam, Chong Sun, Abhishek D. Garg, Jannie Borst, Yanling Xiao

Summary: Despite their low abundance, cDC1s play a crucial role in anti-cancer immunity and are positively associated with patient survival. This study demonstrates that contact with activated CD4(+) T-cells enables cDC1s to induce a CTL response. The transcriptomic signature of helped cDC1s correlates with tumor infiltration by CTLs, Thelper(h)-1 cells, and overall survival.

NATURE COMMUNICATIONS (2023)

Article Multidisciplinary Sciences

Proteomics reveals unique identities of human TGF-β-induced and thymus-derived CD4+ regulatory T cells

Mark Mensink, Ellen Schrama, Eloy Cuadrado, Derk Amsen, Sander de Kivit, Jannie Borst

Summary: This study finds that induced Treg cells in humans have distinct protein expression patterns compared to blood-derived inherent Treg and conventional T cells. While induced Treg cells share some signaling and metabolic proteins with inherent Treg cells, they are more similar to conventional T cells.

SCIENTIFIC REPORTS (2022)

暂无数据